HPV-related Carcinogenesis: Basic Concepts, Viral Types and Variants

Archives of Medical Research

Volumn 40, Issue 6, 2009, Pages 428-434

  Lizano, Marcela ^a,b   Berumen, Jaime ^c,d   García Carrancá, Alejandro ^a,b  

^a INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^d HOSPITAL GENERAL DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

BENIGN TUMOR; CANCER CONTROL; CANCER PATIENT; CAUSE OF DEATH; CELL SPECIFICITY; DEVELOPING COUNTRY; DNA VIRUS; ETHNICITY; GENE EXPRESSION; GENE SEQUENCE; GEOGRAPHIC DISTRIBUTION; HEALTH PROGRAM; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MALIGNANT TRANSFORMATION; MOLECULAR EVOLUTION; NONHUMAN; PERSISTENT VIRUS INFECTION; PUBLIC HEALTH; REVIEW; UTERINE CERVIX CANCER; VIRUS CARCINOGENESIS; VIRUS GENOME; VIRUS ONCOGENE; VIRUS TYPING; WART VIRUS;

CELL TRANSFORMATION, NEOPLASTIC; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; FEMALE; GENES, VIRAL; GENETIC VARIATION; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; UTERINE CERVICAL NEOPLASMS;

EID: 70350070743     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2009.06.001     Document Type: Review

References (68)

1. Doorbar J. The papillomavirus life cycle. J Clin Virol 32S1 (2005) S7-S15
2. Schwarz E., Freese U.K., Gissmann L., et al. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314 (1985) 111-114
3. Schneider-Maunoury S., Croissant O., and Orth G. Integration of human papillomavirus type 16 DNA sequences: a possible early event in the progression of genital tumors. J Virol 61 (1987) 3295-3298
4. Cullen A.P., Reid R., Campion M., et al. Analysis of the physical state of different human-papillomavirus DNAs in intra-epithelial and invasive cervical neoplasm. J Virol 65 (1991) 606-612
5. Berumen J., Unger E.R., Casas L., et al. Amplification of human papillomavirus types 16 and 18 in invasive cervical cancer. Hum Pathol 26 (1995) 676-681
6. Münger K., Phelps W.C., Bubb V., et al. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol 63 (1989) 4417-4421
7. Hawley-Nelson P., Vousden K.H., Hubbert N.L., et al. HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. EMBO J 8 (1989) 3905-3910
8. Alfandari J., Shnitman Magal S., Jackman A., et al. HPV16 E6 oncoprotein inhibits apoptosis induced during serum-calcium differentiation of foreskin human keratinocytes. Virology 257 (1999) 383-396
9. Cheng S., Schmidt-Grimminger D.C., Murant T., et al. Differentiation-dependent up-regulation of the human papillomavirus E7 gene reactivates cellular DNA replication in suprabasal differentiated keratinocytes. Genes Dev 9 (1995) 2335-2349
10. Woodworth C.D., Cheng S., Simpson S., et al. Recombinant retroviruses encoding human papillomavirus type 18 E6 and E7 genes stimulate proliferation and delay differentiation of human keratinocytes early after infection. Oncogene 7 (1992) 619-626
11. Rapp L., and Chen J.J. The papillomavirus E6 proteins. Biochim Biophys Acta 1378 (1998) F1-F19
12. Scheffner M., Werness B.A., Huibregtse J.M., et al. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63 (1990) 1129-1136
13. Dyson N., Guida P., Munger K., et al. Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins. J Virol 66 (1992) 6893-6902
14. Beaudenon S., and Huibregtse J. HPV E6, E6AP and cervical cancer. BMC Biochemistry 9 Suppl 1 (2008) S4
15. Foster S.A., and Galloway D.A. Human papillomavirus type 16 E7 alleviates a proliferation block in early passage human mammary epithelial cells. Oncogene 12 (1996) 1773-1779
16. zur Hausen H. Papillomaviruses: to vaccination and beyond. Biochemistry (Moscow) 73 (2008) 498-503
17. Steenbergen R., de Wilde J., Wilting S., et al. HPV-mediated transformation of the anogenital tract. J Clin Virol 32 Suppl 1 (2005) S25-S33
18. Antinore M.J., Birrer M.J., Patel D., et al. The human papillomavirus type 16 E7 gene product interacts with and trans-activates the API family of transcription factors. EMBO J 15 (1996) 1950-1960
19. Klingelhutz A.J., Foster S.A., and McDougall J.K. Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 380 (1996) 79-81
20. Torrisi A., Del Mistro A., Onnis G.L., et al. Colposcopy, cytology and HPV testing in HIV-positive and HIV-negative women. Eur J Gynecol Oncol 21 (2000) 168-172
21. De Villiers E.M., Fauqet C., Broker T.R., et al. Classification of papillomaviruses. Virology 324 (2004) 17-27
22. Bernard H.U. The clinical importance of nomenclature, evolution, and taxonomy of human papillomaviruses. J Clin Virol 32S (2005) S1-S6
23. Calleja-Macias I.E., Kalantari M., Allan B., et al. Papillomavirus subtypes are natural and old taxa: phylogeny of human papillomavirus types 44 and 55 and 68a and -b. J Virol 79 (2005) 6565-6569
24. Ong C.K., Chan S.Y., Campo M.S., et al. Evolution of human papillomavirus 18: an ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups. J Virol 67 (1993) 6424-6431
25. Yamada T., Manos M.M., Peto J., et al. Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol 71 (1997) 2463-2472
26. Gissmann L., and zur Hausen H. Partial characterization of viral DNA from human genital warts (condyloma acuminata). Int J Cancer 25 (1989) 695-609
27. De Villiers E.M., Gissmann L., and zur Hausen H. Molecular cloning of viral DNA from human genital warts. J Virol 40 (1981) 932-935
28. Gissmann L., Diehl V., Schultz-Coulon H.J., et al. Molecular cloning and characterization of human papilloma virus DNA derived from a laryngeal papilloma. J Virol 44 (1982) 393-400
29. Durst M., Gissmann L., Ikenberg H., et al. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci USA 80 (1983) 3812-3815
30. Boshart M., Gissmann L., Ikenberg H., et al. A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J 3 (1984) 1151-1157
31. Lorincz A.T., Lancaster W.D., and Temple G.F. Cloning and characterization of the DNA of a new human papillomavirus from women with dysplasia of the uterine cervix. J Virol 58 (1986) 225-229
32. Beaudendon S., Kremsdorf F., Croissant O., et al. A novel type of human papillomavirus associated with genital neoplasias. Nature 321 (1986) 246-249
33. Naghashfar Z.S., Roseshein N.B., Lorincz A.T., et al. Characterization of human papillomavirus type 45, a new type 18-related virus of the genital tract. J Virol 68 (1987) 3073-3079
34. Takami Y., Kondoh G., Saito J., et al. Cloning and characterization of human papillomavirus type 52 from cervical carcinoma in Indonesia. Int J Cancer 48 (1991) 516-522
35. Matsukura T., and Sugase M. Molecular cloning of a novel human papillomavirus (type 58) from an invasive cervical carcinoma. Virology 177 (1990) 833-836
36. Muñoz N., Bosch F.X., de Sanjose S., et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348 (2003) 518-527
37. de Sanjose S., Diaz M., Castellsague X., et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 7 (2007) 453-459
38. Gage J.R., Meyers C., and Wettstein F.O. The E7 proteins of the nononcogenic human papillomavirus type 6b (HPV-6b) and of the oncogenic HPV-16 differ in retinoblastoma protein binding and other properties. J Virol 64 (1990) 723-730
39. Ferenczy A., and Franco E. Persistent human papillomavirus infection and cervical neoplasia. Lancet Oncol 3 (2002) 11-16
40. Burd E.M. Human papillomavirus and cervical cancer. Clin Microbiol Rev 16 (2003) 1-17
41. Araujo Souza P.S., Maciag P.C., Ribeiro K.B., et al. Interaction between polymorphisms of the human leukocyte antigen and HPV-16 variants on the risk of invasive cervical cancer. BMC Cancer 8 (2008) 246
42. Ishikawa H., Mitsuhashi N., Sakurai H., et al. The effects of p53 status and human papillomavirus infection on the clinical outcome of patients with stage IIIB cervical carcinoma treated with radiation therapy alone. Cancer 91 (2001) 80-89
43. Sousa H., Santos A.M., Pinto D., et al. Is the p53 codon 72 polymorphism a key biomarker for cervical cancer development? A meta-analysis review within European populations. Int J Mol Med 20 (2007) 731-741
44. Goodman M.T., McDuffie K., Hernandez B., et al. Association of methylenetetrahydrofolate reductase polymorphism C677T and dietary folate with the risk of cervical dysplasia. Cancer Epidemiol Biomarkers Prev 10 (2001) 1275-1280
45. Bernard H.U., Callejas-Macias I.E., and Dunn T. Genome variation of human papillomavirus types: phylogenetic and medical implications. Int J Cancer 118 (2006) 1071-1076
46. Ho I., Chan S.Y., Burk R.D., et al. The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and movement of ancient populations. J Virol 67 (1993) 6413-6424
47. Chen Z., DeSalle R., Schiffman M., et al. Evolutionary dynamics of variant genomes of human papillomavirus types 18, 45, and 97. J Virol 83 (2009) 1443-1445
48. Calleja-Macias I.E., Kalantari M., Huh J., et al. Genomic diversity of human papillomavirus-16, 18, 31, and 35 isolates in a Mexican population and relationship to European, African, and Native American variants. Virology 319 (2004) 315-323
49. Londesborough P., Ho L., Terry G., et al. Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities. Int J Cancer 69 (1996) 364-368
50. Xi L.F., Demers G.W., Koutsky L.A., et al. Analysis of human papillomavirus type 16 variants indicates establishment of persistent infection. J Infect Dis 172 (1995) 747-755
51. Xi L.F., Koutsky L.A., Galloway D.A., et al. Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. J Natl Cancer Inst 89 (1997) 796-802
52. Berumen J., Ordonez R.M., Lazcano E., et al. Asian-American variants of human papillomavirus 16 and risk for cervical cancer. J Natl Can Inst 93 (2001) 1325-1330
53. Hildesheim A., and Wang S.S. Host and viral genetics and risk of cervical cancer: a review. Virus Res 89 (2002) 229-240
54. Lizano M., Berumen J., Guido M.C., et al. Association between human papillomavirus type 18 variants and histopathology of cervical cancer. J Natl Cancer Inst 89 (1997) 1227-1231
55. Lizano M., De la Cruz-Hernández E., Carrillo-García A., et al. Distribution of HPV16 and 18 intratypic variants in normal cytology, intraepithelial lesions, and cervical cancer in a Mexican population. Gynecol Oncol 102 (2006) 230-235
56. De Boer M.A., Peters L.A., Aziz M.F., et al. Human papillomavirus type 18 variants: histopathology and E6/E7 polymorphisms in three countries. Int J Cancer 114 (2005) 422-425
57. Burk R.D., Terai M., Gravitt P.E., et al. Distribution of human papillomavirus types 16 and 18 variants in squamous cell carcinomas and adenocarcinomas of the cervix. Cancer Res 63 (2003) 7215-7220
58. Stöppler M.C., Ching K., Stöppler H., et al. Natural variants of the human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation. J Virol 70 (1996) 6987-6993
59. Chakrabarti O., Veeraraghavalu K., Tergaonkar V., et al. Human papillomavirus type 16 E6 amino acid 83 variants enhance E6-mediated MAPK signaling and differentially regulate tumorigenesis by notch signaling and oncogenic ras. J Virol (2004) 5934-5945
60. Contreras-Paredes A., De la Cruz-Hernández E., Martínez-Ramírez I., et al. E6 variants of human papillomavirus 18 differentially modulate the protein kinase B/phosphatidylinositol 3-kinase (akt/PI3K) signaling pathway. Virology 383 (2009) 78-85
61. De la Cruz-Hernández E., García-Carrancá A., Mohar-Betancourt A., et al. Differential splicing of E6 within human papillomavirus type 18 variants and functional consequences. J Gen Virol 86 (2005) 2459-2468
62. Veress G., Szarka K., Dong X.P., et al. Functional significance of sequence variation in the E2 gene and the long control region of human papillomavirus type 16. J Gen Virol 80 Pt 4 (1999) 1035-1043
63. Kämmer C., Warthorst U., Torrez-Martinez N., et al. Sequence analysis of the long control region of human papillomavirus type 16 variants and functional consequences for P97 promoter activity. J Gen Virol 81 (2000) 1975-1981
64. Ndisang D., Faulkes D.J., Gascoyne D., et al. Differential regulation of different human papilloma virus variants by POU family transcription factor Brn-3a. Oncogene 25 (2006) 51-60
65. Hubert W.G. Variant upstream regulatory region sequences differentially regulate human papillomavirus type 16 DNA replication throughout the viral life cycle. J Virol 79 (2005) 5914-5922
66. Sichero L., Franco E.L., and Villa L.L. Different P105 promoter activities among natural variants of human papillomavirus type 18. J Infect Dis 191 (2005) 739-742
67. López-Saavedra A., González-Maya L., Ponce-de-León S., et al. Functional implication of sequence variation in the long control region and E2 gene among human papillomavirus type 18 variants. Arch Virol 154 (2009) 745-754
68. Ordóñez R.M., Espinosa A.M., Sánchez-González D.J., et al. Enhanced oncogenicity of Asian-American human papillomavirus 16 is associated with impaired E2 repression of E6/E7-oncogenes transcription. J Gen Virol 85 (2004) 1433-1444